Medelpharm has unveiled a new generation of research and development (R&D) press with the STYL’One Nano.
This tool is one of the most advanced benchtop tablet presses available to formulation scientist and academics with price performance in mind. It is fully instrumented with standard B&D tooling, this tablet press is controlled by software in force and displacement. It runs single stroke movements, as well as sawtooth or square profile (elongated dwell time) at speeds way beyond classic single stroke presses. Being able to program pre-compression and main compression allows this press to compete with the R&D rotary presses, producing up to 1,800 tablets per hour.
Vice-president of business development at Medelpharm Ingrid Coyle said: “We are building on the technologies used in our reference STYL’One Evolution to bring to the largest audience flexibilities, which were reserved to an elite.
“We plan to install a STYL’One Nano in every laboratory that is serious about development and could not afford expensive compaction simulators before. We also believe the reference of the USP <1062> becoming more widely used will also create demands for solutions with this level of versatility.”
Head of the technical and production department Thomas Vermeulin added: “The STYL’One Nano builds on the ease-of-use and versatility, which made all Medelpharm product very well received across the market. A compression zone with basically no screws to be easy-to-clean, an elegant design and very strong build are the signatures of our design team. We made a benchtop machine that scientists will be proud to own!”.
The STYL’One Nano comes fully configured, including upper and lower punch instrumentation, PC with analytical software and tablet press control, and B and D punch support. This new tabletting instrument will be available in volume in the second half of 2019.